Management of NTD thalassemia

Jump to section
Monitoring
Unmet Need
Sign Up
BACK TO TOP

Frequent monitoring and management of NTD patients with thalassemia is critical to identify and help mitigate the development of morbidities1,2

Pulmonary hypertension

Iron overload

Hypercoagulability

Thrombotic disease

Liver disease

Endocrine and bone disease

Leg ulcers

Extramedullary hematopoiesis

Patients with thalassemia should receive a long-term thalassemia management plan for optimal care3

Download a Guidelines-Based Monitoring Guide

Stay up to date with the latest
thalassemia management guidelines

Get the TIF Guidelines for NTD Beta-Thalassaemia

Get the TIF Guidelines for Alpha-Thalassaemia

Get the Guidelines for the Management of Transfusion Therapy for Thalassemia

Thalassemia treatment options are needed that target the underlying pathophysiology of thalassemia3

There are currently limited treatment options that specifically target ineffective erythropoiesis and hemolysis in NTD patients with alpha- or beta-thalassemia.

Connect your patients with a Clinical Nurse Educator (CNE), who works closely with patients, families, and their care teams to offer individualized support,* educational resources, and community connections.

Connect with a CNE here

*A Clinical Nurse Educator does not provide medical advice.

For Healthcare Professionals

Stay up to date

Get the latest thalassemia information.

Required field*

References:
1. Musallam KM, Cappellini MD, Coates TD, et al. Alpha-thalassemia: a practical overview. Blood Rev. 2024;64:101165. doi:10.1016/j.blre.2023.101165 2. Taher AT, Musallam KM, Cappellini MD. ß-Thalassemias. N Engl J Med. 2021; 25(8):727-743. doi:10.1056/NEJMra2021838 3. Taher AT, Musallam KM, Cappellini MD. Guidelines for the Management of Non-Transfusion-Dependent β-Thalassemia. 3rd ed. Nicosia, Cyprus: Thalassemia International Federation; 2023.